Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1936.HK Stock Summary
Top 10 Correlated ETFs
1936.HK
In the News
1936.HK Financial details
Company Rating
Buy
Market Cap
245.44M
Income
10.43M
Revenue
121.26M
Book val./share
0.33
Cash/share
0.19
Dividend
-
Dividend %
-
Employees
51
Optionable
No
Shortable
Yes
Earnings
27 Mar 2024
P/E
10.53
Forward P/E
-
PEG
-13.36
P/S
0.89
P/B
0.8
P/C
3
P/FCF
4.95
Quick Ratio
7.45
Current Ratio
14.51
Debt / Equity
0
LT Debt / Equity
-
-
-
EPS (TTM)
0.02
EPS next Y
-
EPS next Q
-
EPS this Y
-0.41%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-5.47%
Revenue last 5Y
0.85%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-50%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
8%
ROC
0.11%
Gross Margin
24%
Oper. Margin
12%
Profit Margin
8%
Payout
-
Shs Outstand
472M
Shs Float
107.02M
-
-
-
-
Target Price
-
52W Range
0.34-2.18
52W High
-
52W Low
-
RSI
73
Rel Volume
2.73
Avg Volume
526.19K
Volume
1.44M
Perf Week
7.55%
Perf Month
44.3%
Perf Quarter
-66.07%
Perf Half Y
-66.27%
-
-
-
-
Beta
-0.329
-
-
Volatility
0.02%, 0.05%
Prev Close
0%
Price
0.57
Change
-3.39%
1936.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.26 | 0.25 | 0.25 | 0.24 | 0.28 | |
Net income per share | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
Operating cash flow per share | 0.05 | -0.01 | 0.02 | 0.01 | 0.05 | |
Free cash flow per share | 0.05 | -0.01 | 0.02 | 0.01 | 0.05 | |
Cash per share | 0.03 | 0.02 | 0.15 | 0.11 | 0.16 | |
Book value per share | 0.14 | 0.17 | 0.31 | 0.29 | 0.31 | |
Tangible book value per share | 0.14 | 0.17 | 0.31 | 0.29 | 0.31 | |
Share holders equity per share | 0.14 | 0.17 | 0.31 | 0.29 | 0.31 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 728.09M | 724.64M | 129.65M | 136.54M | 231.56M | |
Enterprise value | 724.04M | 719.7M | 114.54M | 124.99M | 187.73M | |
P/E ratio | 45.77 | 52.82 | 15.34 | 11.53 | 20.47 | |
Price to sales ratio | 5.66 | 5.75 | 1.12 | 1.14 | 1.73 | |
POCF ratio | 30.91 | -223.72 | 13.63 | 32.65 | 9.34 | |
PFCF ratio | 31.68 | -184.43 | 15.8 | 39.81 | 9.62 | |
P/B Ratio | 10.32 | 8.6 | 0.92 | 0.97 | 1.56 | |
PTB ratio | 10.32 | 8.6 | 0.92 | 0.97 | 1.56 | |
EV to sales | 5.63 | 5.71 | 0.99 | 1.04 | 1.4 | |
Enterprise value over EBITDA | 31.26 | 35.34 | 8.25 | 7.03 | 10.25 | |
EV to operating cash flow | 30.74 | -222.2 | 12.04 | 29.89 | 7.57 | |
EV to free cash flow | 31.5 | -183.18 | 13.96 | 36.44 | 7.8 | |
Earnings yield | 0.02 | 0.02 | 0.07 | 0.09 | 0.05 | |
Free cash flow yield | 0.03 | -0.01 | 0.06 | 0.03 | 0.1 | |
Debt to equity | 0.03 | 0.02 | 0 | 0 | 0 | |
Debt to assets | 0.02 | 0.02 | 0 | 0 | 0 | |
Net debt to EBITDA | -0.17 | -0.24 | -1.09 | -0.65 | -2.39 | |
Current ratio | 4.44 | 7.48 | 17.51 | 10.75 | 14.51 | |
Interest coverage | 1.48K | 129.68 | 250.94 | 522.19 | 688.67 | |
Income quality | 1.06 | -0.17 | 0.76 | 0.26 | 1.49 | |
Dividend Yield | 0.03 | 0 | 0 | 0 | 0 | |
Payout ratio | 1.32 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.07 | 0.03 | 0.12 | 0.09 | 0.08 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.02 | 0.21 | -0.14 | -0.18 | -0.03 | |
Capex to revenue | 0 | -0.01 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -0.58 | -0.48 | -0.97 | -0.47 | -0.4 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.32 | 0.32 | 0.36 | 0.39 | 0.41 | |
ROIC | 0.22 | 0.16 | 0.06 | 0.08 | 0.08 | |
Return on tangible assets | 0.18 | 0.14 | 0.06 | 0.08 | 0.07 | |
Graham Net | 0.02 | 0.08 | 0.21 | 0.17 | 0.22 | |
Working capital | 56.76M | 70.71M | 126.62M | 122.45M | 134.97M | |
Tangible asset value | 70.52M | 84.24M | 140.71M | 140.68M | 148.6M | |
Net current asset value | 56.2M | 70.07M | 125.99M | 121.81M | 134.41M | |
Invested capital | 0.03 | 0.02 | 0 | 0 | 0 | |
Average receivables | 0 | 17.54M | 30.24M | 25.26M | 24.5M | |
Average payables | 9.28M | 8.27M | 6.45M | 7.78M | 8.69M | |
Average inventory | 29.83M | 29.8M | 33.26M | 42.16M | 44.63M | |
Days sales outstanding | 0 | 101.56 | 79.99 | 76.32 | 64.93 | |
Days payables outstanding | 36.55 | 27.59 | 22.69 | 39.52 | 26.38 | |
Days of inventory on hand | 110.83 | 119.21 | 141.97 | 195.53 | 142.33 | |
Receivables turnover | 0 | 3.59 | 4.56 | 4.78 | 5.62 | |
Payables turnover | 9.99 | 13.23 | 16.08 | 9.24 | 13.84 | |
Inventory turnover | 3.29 | 3.06 | 2.57 | 1.87 | 2.56 | |
ROE | 0.23 | 0.16 | 0.06 | 0.08 | 0.08 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0.07 | 0.07 | 0.06 | 0.06 | |
Net income per share | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Operating cash flow per share | 0 | 0.02 | 0.02 | 0.01 | 0.01 | |
Free cash flow per share | 0 | 0.02 | 0.02 | 0.01 | 0.01 | |
Cash per share | 0 | 0.1 | 0.16 | 0.13 | 0.19 | |
Book value per share | 0 | 0.31 | 0.31 | 0.33 | 0.33 | |
Tangible book value per share | 0 | 0.31 | 0.31 | 0.33 | 0.33 | |
Share holders equity per share | 0 | 0.31 | 0.31 | 0.33 | 0.33 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 267.34M | 231.61M | 260.48M | 508.96M | |
Enterprise value | -22.48M | 223.42M | 187.77M | 203.2M | 452.09M | |
P/E ratio | 0 | 27.35 | 23.69 | 23.51 | 45.93 | |
Price to sales ratio | 0 | 8.6 | 7.45 | 8.81 | 17.22 | |
POCF ratio | 0 | 30.99 | 26.85 | 38.02 | 74.28 | |
PFCF ratio | 0 | 31.71 | 27.47 | 39.61 | 77.39 | |
P/B Ratio | 0 | 1.8 | 1.56 | 1.68 | 3.29 | |
PTB ratio | 0 | 1.8 | 1.56 | 1.68 | 3.29 | |
EV to sales | 0 | 7.19 | 6.04 | 6.87 | 15.29 | |
Enterprise value over EBITDA | 0 | 41.45 | 34.84 | 63.52 | 141.32 | |
EV to operating cash flow | 0 | 25.9 | 21.77 | 29.66 | 65.98 | |
EV to free cash flow | 0 | 26.5 | 22.27 | 30.9 | 68.74 | |
Earnings yield | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0.03 | 0.04 | 0.03 | 0.01 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | -8.15 | -8.13 | -17.91 | -17.78 | |
Current ratio | 11.01 | 14.51 | 14.51 | 14.68 | 14.68 | |
Interest coverage | 0 | 0 | 494.99 | 0 | 93.38 | |
Income quality | 0 | 3.53 | 3.53 | 2.47 | 2.47 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.07 | 0.07 | 0.09 | 0.09 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | -0.02 | -0.02 | -0.04 | -0.04 | |
Capex to revenue | 0 | -0.01 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | 0 | -0.45 | -0.45 | -0.61 | -0.61 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0.19 | 0.19 | 0.21 | 0.21 | |
ROIC | 0 | 0.02 | 0.02 | 0.01 | 0.01 | |
Return on tangible assets | 0 | 0.02 | 0.02 | 0.02 | 0.02 | |
Graham Net | 0 | 0.16 | 0.22 | 0.18 | 0.24 | |
Working capital | 129.53M | 134.97M | 134.97M | 140.97M | 140.97M | |
Tangible asset value | 147.89M | 148.6M | 148.6M | 155.54M | 154.92M | |
Net current asset value | 128.92M | 134.41M | 134.41M | 140.97M | 140.35M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 11.93M | 23.87M | 23.3M | 22.73M | |
Average payables | 0 | 8.46M | 7.39M | 7.4M | 7.41M | |
Average inventory | 0 | 43.4M | 39.86M | 36.59M | 33.31M | |
Days sales outstanding | 0 | 69.14 | 69.14 | 69.19 | 69.19 | |
Days payables outstanding | 0 | 27.71 | 27.71 | 28.77 | 28.77 | |
Days of inventory on hand | 0 | 149.49 | 149.49 | 129.4 | 129.4 | |
Receivables turnover | 0 | 1.3 | 1.3 | 1.3 | 1.3 | |
Payables turnover | 0 | 3.25 | 3.25 | 3.13 | 3.13 | |
Inventory turnover | 0 | 0.6 | 0.6 | 0.7 | 0.7 | |
ROE | 0 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
1936.HK Frequently Asked Questions
What is Ritamix Global Limited stock symbol ?
Ritamix Global Limited is a MY stock and trading under the symbol 1936.HK
What is Ritamix Global Limited stock quote today ?
Ritamix Global Limited stock price is $0.57 today.
Is Ritamix Global Limited stock public?
Yes, Ritamix Global Limited is a publicly traded company.